Abstract. Tat, the transactivation factor of human immunodeflciency virus type 1 (HIV-1), contains the highly conserved tripeptide sequence Arg-Gly-Asp (RGD) that characterizes sites for integrin-mediated cell adhesion. The tat protein was assayed for cell attachment activity by measuring the adhesion of monocytic, T lymphocytic, and skeletal muscle-derived cell lines to tat-coated substratum. All cell lines tested bound to tat in a dose-dependent manner and the tat cell adhesion required the RGD sequence because tat mutants constructed to contain an RGE or KGE tripeptide sequence did not mediate efficient cell adhesion. The tat-mediated cell attachment also required divalent cations and an intact cytoskeleton. In addition, cell adhesion to tat was inhibited in the presence of an RGD-containing peptide GRGDSPK or an antitat mAb that recognizes the RGD epitope. These results strongly suggest that cells are bound to tat through an integrin. Interestingly, myoblast cells bound to tat remained round, whereas the same cells attached through an integrin for a matrix protein typicaUy flatten and spread. The role of this RGD-dependent cellular adhesion of tat in HIV-1 infection remains to be determined. p ROTEINS that interact with integrin cell adhesion receptors frequently contain the amino acid tripeptide RGD sequence (5, 20, 26, 30) within the integrin binding site. RGD sequences are found in fibronectin, vitronectin and collagen and constitute extracellular matrix attachment sites used for integrin-mediated cell adherence during development and differentiation (30). Integrin receptors on leukocytes bind to coagulation proteins (von Willebrand factor, fibrinogen, thrombospondin) and complement components (C3b), and participate in cell-cell adhesion (LFA-1 with I-CAM). These interactions are involved in homeostatic regulation, phagocytosis, cell migration, cell signaling, cellular trafficking, and lymphocyte recognition (11, 23, 30, 39) . In addition, certain bacterial, parasitic, and viral proteins possess RGD sequences which recognize integrin receptors and may contribute to pathogenesis (1, 30, 31).
cated in the carboxy-terminal portion of the protein and is highly conserved among HW-1 isolates ( Fig. 1) (24) . The presence of an RGD sequence within tat raised the intriguing possibility that this tripeptide could constitute a cell attachment site. In this study, purified tat protein was assayed for cell attachment to various cell types. The observed cell adhesion was further characterized using an RGD-containing peptide, anti-tat mAbs and mutant tat proteins which contained amino acid substitutions within the RGD sequence.
M a t e r i a l s a n d M e t h o d s

Construction of HIV-I tat Bacterial Expression Vectors
Construction of the full-length tat (HTLV-IIIB isolate) bacterial expression plasmid, pOTS-TATflI, was previously described (2) . The RGE tat (Fig. 1 , mutant 1) expression vector was constructed as follows. An Nde I-Xba I 582-bp fragment from pOTS-TATBI was gel purified and subeloned into the polylinker region of plasmid pUC19 using T4 DNA ligase. The resulting plasmid, pUC19TAT.WT, was digested with Ava I and Xba I and then ligated to a 35-bp Ava I-Xba I synthetic oligonucleotide to generate pUC19TAT.RGE. This synthetic oligonucleotide reconstitutes the 3' end of the tat gene with a single base substitution changing Asps0 to Glu. A Barn HI-Xba 1 253-bp fragment containing the full-length mutated tat gene was purified from pUC19TAT.RGE and then ligated into the Bam HI-Xba I site of pOTS-TATIII. The KGE tat (Fig. 1 , mutant 2) expression vector was similarly constructed except that a 35-bp Ava I-Xba I synthetic oligonucleotide contalning a double base substitution (changing ArgTs to Lys and Aspso to Glu) was used. These mutations were confirmed by dideoxy DNA sequencing (32) using an appropriate sequencing primer. and exon 2 (14 amino acids). The amino acid sequence of the second exon from the HTLV-IIIB isolate (3) is shown. The RGE (mutant 1) and KGE (mutant 2) tat mutants were constructed, expressed, and purified as described in Materials and Methods.
Purification of gqld-7)~pe and Mutant tat Proteins
Escherichia coli (strain ARI20) bacterial cells containing the respective pOTS expression vectors were grown in LB broth containing 50 #g/mi ampicillin at 37°C to OD 0.4 (650 ran) and induced by the addition of 60 #g/ml nalidixic acid as described (2). 5 h after induction sonicated cell lysates were centrifuged (15,000 g) and supernatants were acidified by slow addition of 1 M HC1 to pH 3.0 to precipitate nucleic acids. After centrifugation and neutralization to pH 7.5 using 1.5 M "lYis base (pH 8.5), samples were applied to a Sephadex G-25F column (Pharmacia Fine Chemicals, Piscataway, NJ) (1 x 40 cm) equilibrated in 50 mM NAMES, pH 6.5. The protein peak was pooled and concentrated 10-fold using an Amicon YM-5 membrane (Amicon Corp., Danvers, MA).
Samples were then applied to individual anti-tat iramunoniYinity columns (3 ml bed volume) equilibrated in PBS (pH 7.4). Columns were prepared by coupling purified anti-tat mAb (see below) to cyanogen bromide-activated Sepharose 413 (Pharmacia Fine Chemicals) using manufacturers' recommended conditions. The columns were washed with PBS and the flowthrough material reapplied twice prior to elution. Bound samples were eluted (100 mM sodium citrate/0.5 M NaC1, pH 3.0), protein peaks pooled, and immediately neutralized to pH 7.5 using solid Tris base. Immunoaffinity purification was monitored by SDS-PAGE using Coomassie blue staining and Western blot analysis as previously described (2) . Samples were concentrated, protein concentrations were determined by the method of Bradford (7), and samples were then stored at 4°C until use.
Cell Culture
The human T lymphocytic HUT-78 and MOLT-4 suspension cell lines, the human myelomonocyfic THP-1 suspension cell line and the rat skeletal muscle-derived Ls adherent myoblasts were obtained from American Type Culture Collection (Rockville, MD or Camden, N J). All cell lines were grown and routinely subpassuged in DME supplemented with 10% FBS (Oibco Laboratories, Grand Island, NY), 2 mM L-glutamine, 10 U/mi penicillin G, and 10 ~,g/mi streptomycin (DME).
Cell Adhesion Assay
For the adhesion assay (29), a polystyrene plate (Linbro 76-203; non-tissue culture treated, Flow Laboratories, Maclean, VA) was coated overnight at 37°C with wild-type tat, mutant tat proteins, or the matrix protein vitronectin. Vitronectin was purified according to the method of Dahlback (12) . The plate was washed with PBS, and with DME, and 0.1 mi of DME was added to each well. The adherent I~ myoblasts were suspended by trypsinization and washed three times with trypsin inhibitor (0.5 mg/ml sterile PBS); HUT-78, MOLT-4, and THP-1 cells were washed three times in PBS; 100 ~l of each cell suspension was added to wells in quadruplicate (l x 106 cells/ml in DME). The cells were incubated in the coated wells for I h, fixed with 4% formalin and stained with 1% toluidine blue. Cell adherence was quantitated using a microtiter plate reader (Dynatech Laboratories, Chantilly, VA) set at 570 nM. In some experiments, the cells were incubated with 20 mM EDTA, or cytochalasin B and colchicine, separately or in combination, at l0 ~g/ml each for 30 min at 4°C, and then added to the proteincoated wells. For the mAb inhibition experiments, the coated plate was incubated for 30 min with mAb and washed; then the cells were added.
A polystyrene plate (Linbro) was coated with wild-type and mutant tat proteins (5 ~g/ml in 100 mM NaI-ICO3/Na2CO3, pH 9.4) overnight at 4°C. The plate was washed with Tris-buffered saline, 0.5% Tween-20, pH 8.0 (TBST) and unbound sites blocked with TBST/0.5% gelatin for 1 h. After washing, a 1/1,000 dilution (TBST) of a mouse anti-tat mAb specific for the amino terminal portion of tat (mAb l, ref. 9) was added, incubated for 3 h, washed with TBST and a 1/2,000 dilution of biotin-conjugated affinitypurified goat anti-mouse IgG (Cappel Laboratories, West Chester, PA) added. After 1 h, wells were washed and a 1/2,000 dilution of alkaline phosphatase-conjugnted avidin (Cappel Laboratories) was added for 1 h. Wells were washed thoroughly and bound enzyme was detected using the substrate p-nitrophenyl phosphate (Sigma 104; Sigma Chemical Co., St. Louis, MO) in 0.1 M glycine, pH 10.4, I mM ZnCl2, l mM MgCl2 buffer. The enzymatic reaction was stopped by the addition of 5 N NaOH, and the optical density measured at 405 nm.
Peptide Synthesis
The peptides GRGDSPK and GRADSPK were synthesized as carboxyterminal amides using FMOC chemistry with the RAMPS system (Du Pont Corp., Wilmington, DE). Amino acids and other reagents were obtained from Du Pont Corp.; all solvents were of the highest grade available. The synthesis was performed according to manufacturer's instructions by deblocking the RapidAmide resin with piperidine/DMF; washing alternatively with DMF and methanol; adding the FMOC-amino acid and rocking for 2 h; washing with DMF and methanol, and then testing by ninhydrin reaction; repeating these steps for each amino acid. The peptide was cleaved from the resin and blocking groups removed with trifluoroacetic acid/l,2-ethanedithiol/phenol. The eluted peptide was precipitated with diethyl ether, and washed with ether and then with ether/ethyl acetate 1:1. The peptides were purified on a FPLC Mono S column (Pharmacia LKB Biotechnology, Piscataway, NJ). The sample was applied in 50 mM NaPO4, pH 3.0, 30% acetonitrile, and the column developed with a linear NaCI gradient to 0.35 M. The column eluent was monitored at OD214. The peptides eluted as single peaks, and each contained the appropriate molar ratios of amino acids by compositional analysis (Protein Structure Laboratory, Wistar Institute, Philadelphia, PA).
Anti-tat mAbs
The characterization of the murine anti-tat mAbs used has recently been reported (9) . The mAbs were purified from ascitic fluid by passage through glass wool to remove cellular debris. The IgG fraction from each sample was purified by chromatography on 2-mi columns of Affi-Gel Protein A MAPSII (Bio-Rad Laboratories, Richmond, CA) according to the manufacturer specifications. Eloates were dialyzed overnight at 4°C against 50 mM Hepes pH 7.0, 150 mM NaC1, and concentrated using Centricon-10 (Amicon Corp., Danvers, MA) cartridges. Protein concentration was determined as above and mAbs were stored at 4°C until use.
Results
Cell Adhesion to tat and Mutant tat Proteins
To test the hypothesis that tat can mediate cell adhesion, purified recombinant tat protein was assayed for attachment of various cultured cell lines. Because of the known HIV-1 tropism for T lymphocytes and monocyte/macrophage cells, the HIV-1 replication-competent human T lymphocytic cell lines HUT-78 and MOLT-4 and the human myelomonocytic cell line THP-1 (21, 22, 36) were selected for initial studies. In addition to these cell lines, a rat skeletal muscle cell line, Ls, was also utilized because of its restricted adhesion properties (8) . To assay for cell adhesion, microtiter wells were coated with immunoaffinity-purified tat protein, seeded with cells, and incubated for 1 h. tat-mediated cell adhesion was quantitated by optical density measurement after toluidine blue staining. As shown in Fig. 2 , tat was highly efficient in 
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Protein Coaled O~g/ml) Figure 2 . Dose response of the cell adhesion to wild-type and RGE mutant tat. The adherence of cells to protein-coated wells of a 96-well microtiter plate was measured by optical density reading (570 nm) after incubation and staining as described in Materials and Methods. Shown is the adherence of rat skeletal L8 myoblasts, human T lymphocytic HUT-78 cells, human T lymphocytic MOLT-4 cells, and human monocytic THP-1 cells to wells coated with purified recombinant wild-type (o) or RGE mutant tat protein (*) at increasing concentrations. SE in all experiments were +0.025 OD570. Note the difference in the abscissa and ordinate scales since assays were performed at different times.
mediating cell adherence of all four cell lines tested. The tatmediated adhesion was dose dependent and the tat coating concentration, which gave half-maximal cell adhesion, was between 1 and 5/~g/ml (0.1-0.5/zM). For each cell line the level of adherence to tat-coated wells was equivalent to the highest level of binding obtained with control matrix proteins (Fig. 4 and data not shown).
To determine the role of the tat RGD-tripeptide sequence in the cell adhesion, two tat mutants were constructed which contained the conservative replacement sequences RGE and KGE. The single amino acid Ds0-E substitution was selected since the overall net charge of tat would not be affected and an RGD-RGE substitution has been shown to abrogate cell binding to fibronectin (25) . This D-E change was sufficient to significantly reduce or completely eliminate tat-mediated cell binding (Fig. 2) . The mutation completely eliminated the adherence of I~ cells and reduced the binding (40-90%) of the HUT-78, MOLT-4 and THP-1 cells. The L8 myoblasts did not adhere to the mutant RGE tat protein even when wells were coated at concentrations up to 120/zg/ml, whereas wild-type RGD tat protein coated at 1 #g/ml or more mediated efficient cell adhesion.
To further investigate the involvement of the tripeptide RGD sequence of tat in cell attachment, a second mutant tat protein was constructed containing conservative amino acid substitutions at both the arginine and aspartic residues (Fig.  1, mutant 2) . This KGE mutant tat protein also completely lacked cell attachment activity for L8 cells (Fig. 3) . The adhesion of the other cell lines to the KGE double mutant was only slightly above background and was therefore more drastically reduced as compared with the adhesion to the single RGE mutant tat protein (Fig. 3) . The adhesion was performed several times at a single protein concentration (5/~g/ ml) since insufficient quantities of purified KGE mutant protein were available to perform a full dose response. The lack of cell adhesion to the RGE and KGE mutant tat proteins could not be attributed to binding of lower levels ofmutam tat to the wells, since similar amounts of anti-tat mAb bound to wells coated with either wild-type tat (0.88 ± 0.04 OD40s), mutant RGE (0.93 ± 0.04), or mutant KGE (0.79 ± 0.07) tat protein as judged by ELISA.
tat-mediated Cell Adhesion Is Dependent on Divalent Cations and an Intact Cytoskeleton, and Is Inhibited by an RGD-containing Peptide
The negative effect of tat mutations at the RGD site on cell adhesion suggested that cell binding could involve the partic- ipation of an integrin. To further investigate this possibility, the effect of EDTA, cytoskeletal blockers, and an RGD-containing peptide on cell adhesion was investigated. For these investigations the skeletal muscle-derived L8 cell line was used because this line has been characterized for integrin expression and has been found to adhere primarily to vitronectin but not to fibronectin, laminin, or collagen (8) . It was felt that the restricted integrin distribution of ~ cells would allow for a more straightforward interpretation of the results. Several integrins have been shown to require divalent cations such as Ca 2+ or Mg 2+ for binding to their ligand and there is strong evidence that integrins are connected to the cytoskeleton (20, 30) . We observed that the interaction between tat and L8 cells was dependent on divalent cations. Indeed, the addition of EDTA abrogated cell attachment ( Fig. 4) and adherence was restored by the addition of either Ca 2+ or Mg 2+ (data not shown). In addition, cell attachment required an intact cytoskeleton, as cell binding was eliminated in the presence of cytochalasin B plus colchicine (Fig.  4) . These results are all consistent with integrin-mediated cell attachment (29, 30) . RGD-containing peptides are known to compete with several ligands for binding to their respective integrin (20, 30) . Accordingly, we examined the effect of an RGD-contalning peptide on the tat-mediated cell adhesion. As shown in Fig.  5 , the L8 cell attachment to tat was abrogated by addition of the synthetic peptide GRGDSPK. This peptide reduced the cell adherence to background levels when present at concentrations >100 #g/ml (0.1 mM). ~ cell attachment to the control matrix protein vitronectin was inhibited at similar levels of the peptide (data not shown). In contrast, the control synthetic peptide, which contained an RAD sequence, did not block cell attachment at concentrations up to 5 mg/ml (Fig. 5) . These results are also consistent with integrinmediated cell attachment.
Specific Inhibition of tat-mediated Cell Attachment by Anti-tat mAb 9
A panel of murine mAbs reactive with HIV-1 tat have been recently mapped and epitopes defined using Pepscan analysis (9) . One mAb, designated mAb 9, was found to react with nonapeptides spanning sequences at the carboxy-terminal end of tat and the critical residues for binding were found to be centered on the RGD site. Moreover, RGE and KGE mutant tat proteins were no longer recognized by mAb 9, but retained reactivity to other mAbs (Brake, D., unpublished observations). In the present study, we asked if mAb 9 could inhibit L8 myoblast attachment to tat-coated wells (Fig. 6) . A 50 % reduction in cell attachment was found at 25 #g/ml and approached background levels (0.05 ODs~0) at 250 #g/ ml. Inhibition was specific since the control mAb 1, which recognizes an amino-terminal epitope, failed to efficiently block cell attachment. Neither mAb 1 nor mAb 9 inhibited cell attachment on vitronectin substrates (data not shown). These data further demonstrate that the RGD site on tat is involved in Lg cell adhesion. was that Ls myoblasts remmned round after attachment (Fig 7 a) , whereas when bound to vltronectm the Ls cells were spread, flattened, and had numerous projections (Fig  7 b ) Cell spreading was also found for Ls cells bound nonspecifically to tissue culture-treated plastic or poly-lysine (data not shown) Absence of cell spreading on tat was also noted for the T lymphocytic and myelomonocytlc cell lines The distinct morphology of Ls cells bound to tat suggests that events after binding leading to cytoskeletal reorgamzatmn differ for cells bound to tat compared with cells bound to extracellular matrix proteins such as wtronectin
Cell Morphology of tat-mediated Cell Adhesion
D i s c u s s i o n
The HIV-1 tat gene is composed of two coding exons which d~rect the synthesis of an 86 amino acid-long protein The second exon codes for 14 anuno acids, which Include the trlpeptide sequence RGD, wh]ch ~s highly conserved among HIV-1 ~solates sequenced to date (24) Since the RGD sequence shared among many extracellular hgands Is thought to play a crucial role in cell adhesion (30) , purified recombinant tat protein was assayed for cell attachment using several different cell lines tat was shown to mediate attachment of T lymphocyUc, myelomonocytlc, and muscle-derived cell hnes In a dose-dependent manner To test that adherence was specific, and not the result of runic interactions w~th the highly basic tat protein (two lysInes and six argtmnes over nine residues), the tat-mediated cell adhesion was further tested using tat mutauons m the consensus RGD sequence Two different mutants containing alterations at the consensus RGD sequence site were constructed, expressed, purified and tested for their cell attachment activity Inmally, a conservative Asps0 to Glu amino acid subsUtutlon was chosen since this mutaUon could alter specific interactions without affecting any nonspeclfiC lomc interactions and this type of mutation has been shown to abrogate the cell adhesion activity of fibronectln (25) The single RGD to RGE mutation completely abrogated tat-medmted cell adhesmn to Figure 7 Morphology of cells attached to RGD-contmmng proteins Ls cells seeded on tat remained round (A), m contrast to L8 cells seeded on v|tronectm-coated substratum (B), which were spread and flattened with numerous projections Similar results were obtained whether L8 cells were incubated 1 h or overnight on the protein-coated substratum The cell adherence was analyzed after suspensmn of the mononucleated Ls myoblasts with trypsin, washing with trypsin inhibitor (0 5 mg/ml PBS) and seeding at l0 s cells/well m protein-coated wells of a m|crotiter plate Ls cells over a wide dose range, and produced a slgmficant but less dramatic effect on the adhesion of the human T lymphocytic and monocyUc cell lines Furthermore, a second tat mutant in which the RGD was changed to KGE also failed to efficiently bind Ls myoblasts, and reduced the cell attachment of the HUT-78, MOLT-4 and THP-1 cell lines almost to background levels The observed chfferences between the various cell lines in their bmchng to the wild-type and tat mutants could result from different levels of expression of a specific cell receptor, possibly an lntegnn receptor To test the hypothesis that tat directly interacts w~th a functmnal lntegnn, additional experiments were conducted using reagents known to block hgand-lntegnn lnteractmns tat-me&ated cell binding was completely elmunated in the presence of either the metal chelator EDTA or the cytoskeletal blockers cytochalasin B and colchicine, agents that have been shown to inhibit several other hgand-integnn interacaons (20) In addition, the ~ cell attachment to tat was also inhibited by an RGD-contalmng pepade but not by a control RAD-containing peptide. The inhibition by GRGDSPK is somewhat surprising, since the RGD tripeptide in tat is followed by a highly conserved proline and a proline residue could markedly affect conformation-dependent interactions. However, initial attempts to inhibit tat cell attachment with a proline-containing peptide SRGDPT based on the tat sequence have not been successful, suggesting that protein regions outside of the tat tripeptide may stabilize a particular RGD conformation. The results obtained with anti-tat mAb 9 further support the notion that the RGD tripeptide in tat participates in cell adhesion. Immunoprecipitation experiments are currently in progress to further characterize the putative tat cell surface receptor.
Integrin alpha-subunits contain calcium-binding sequences involved in stabilizing the protein structure and in ligand binding (20, 30) . The alpha and beta int¢grin subunits both contain a small cytoplasmic domain which can interact with the cytoskeleton matrix (10, 11, 37) . Integrin-mediated binding to vitronectin and other matrix proteins is typically associated with integrin aggregation and cytoskeletal reorganization of microfilaments and microfilament-associated proteins, such as talin and vinculin (10, 11) . l-,s myoblasts bound to vitronectin were spread and displayed numerous projections typical of integrin-mediated binding to matrix proteins. In contrast, although cell binding to tat involved the cytoskeleton, the Ls cells on tat did not spread. The morphological appearance of cells bound to tat is similar to the morphology of hematopoietic cells bound to RGD-containing proteins, where reorganization of cytoskeletal structures occurs in the absence of cell spreading (10) . These results indicate that while cells may bind to tat through an RGD-dependent integrin interaction, the cell binding may not involve the vitronectin receptor or related matrix protein integrin.
The identification of a highly conserved functional RGD site on HIV-1 tat is the first example, to our knowledge, of a specific cell adhesion site on a retrovirally encoded regulatory protein. The identification of a cell attachment site on tat indicates that tat binds to a specific cell surface protein, possibly an integrin. It will be interesting to examine the role of RGD-mediated adhesion in the exogenous transactivation of tat recently described (15, 16, 19) . The RGD-mediated tat binding could promote tat cellular uptake in vivo and subsequent transactivation of virus in latently infected cells. Alternatively, tat uptake could lead to aberrant gene expression in uninfected cells, such as that observed in tat transgenic mice (38) . tat binding could also directly stimulate viral and/or cell function without requiring cell uptake. The location of the highly conserved RGD sequence in a separate exon also raises the possibility that the cell attachment site could be incorporated into other viral proteins by alternate splicing. Characterization of this cell adhesion site and its importance for tat function and HIV-1 infection will require the precise elucidation of the mechanism of action of tat transactivation as well as the isolation of the tat cell receptor.
